KFG
BEAM icon

Kingdom Financial Group’s Beam Therapeutics BEAM Stock Holding History

Kingdom Financial Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18 Hold
1
– – ﹤0.01% 830
2025
Q4 		$21 Buy
+1
New +$26 ﹤0.01% 719

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Kingdom Financial Group's BEAM Position: Q1 2026 in Review

Kingdom Financial Group held its Beam Therapeutics (BEAM) position steady in Q1 2026 at 1 share worth $18. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Kingdom Financial Group first reported a position in BEAM in Q4 2025 and has held it in 2 quarters since. The position peaked at $21 in Q4 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Kingdom Financial Group held 1 share of Beam Therapeutics worth $18 as of Q1 2026.
  • Kingdom Financial Group left its Beam Therapeutics share count unchanged in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of Kingdom Financial Group's portfolio in Q1 2026, its #830 holding.
  • Kingdom Financial Group first reported a position in Beam Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Kingdom Financial Group's Beam Therapeutics position peaked at $21 in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Kingdom Financial Group's 13F filing for Q1 2026, filed 13 May 2026.